Press Release: July 09, 2020

NuMedii Announces Creation of World’s First Single-Cell Sequencing Atlas for Idiopathic Pulmonary Fibrosis by its Collaborators

Press Release: Jan. 15, 2020

NuMedii, Inc. Announces Pharmaceutical Discovery Collaboration For Ulcerative Colitis

Press Release: November 01, 2018

NuMedii Names Industry Veteran Heather Arnett, Ph.D. as Vice President of Research

Press Release: November 01, 2018

NuMedii Announces Research Collaboration With Leading Academic Research Institution to Explore New Targets and Therapeutics for Pancreatitis

Conference: October 2018

NABE Tech Economics Conference (TEC)
Sponsor: National Association for Business Economics (NABE)
Topic: Applications of Machine Learning in Non-Tech Sectors
October 28-30, 2018
COEX, Seoul, South Korea

Conference: October 2018

AI Pharma Korea
Sponsor: Korea Pharmaceutical and Bio-Pharma Manufacturers Association(‘KPBMA’)
Topic: How to Use AI to Generate Novel Drug Candidates
October 15, 2018
COEX, Seoul, South Korea

Conference: October 2018

5th Annual Drug Discovery USA Congress
Title : Using Machine Learning To Identify New Targets For Fibrosis
October 11-12, 2018
San Diego, CA

Conference: October 2018

ISWC 2018 (2018 International Semantic Web Conference)
Title : Accelerating Drug Discovery in Rare and Complex Diseases
October 8-10, 2018
Monterey, CA

Conference: September 2018

Evolution Summit
Title : The Next Big Thing: Revolutionizing Drug Discovery
through Artificial Intelligence (AI)
September 24-26, 2018
Dallas, TX

Press Release: July 10, 2018

NuMedii Announces Strategic Research Collaboration with Two Leading Academic Research Institutions Utilizing Single-Cell Sequencing to Identify Precision Therapeutics for IPF

Press Release: June 20, 2018

NuMedii Expands Board of Directors and Scientific Advisory Board with the Addition of Two Oncology Experts

Applied AI – January, 2018

14 Healthcare AI Applications

Pulmonary Fibrosis News – January, 2018

NuMedii Advances IPF Personalized Medicine with New Advisory Board to Guide AI Approach

Medical Device and Diagnostic Industry (MD+DI) – January, 2018

Sifting Nuggets of Truth out of the AI Hooplah

MedCity News – January, 2018

Andy Slavitt: When it comes to AI, it is the best of times, worst of times story

Press Release: January 5, 2018

World’s Leading Lung Disease Experts Join NuMedii’s Idiopathic Pulmonary Fibrosis Advisory Board

WuXi AppTec – October, 2017

Inside Perspectives: NuMedii Banking on Artificial Intelligence to Expedite the Discovery of Effective New Medicines

PharmTech – September, 2017

Expediting the Discovery and Development of Drugs – Drug repurposing, repositioning, and rescue can be faster, cheaper, and target more diseases than traditional drug discovery approaches

Press Release: April 11, 2017

NuMedii, Inc. Announces New Partnership To Discover And Advance New Treatments For Idiopathic Pulmonary Fibrosis

The Scientist – January, 2017

Repurposing Existing Drugs for New Indications

View press release archive…


Follow us on Twitter

1 year ago
Many thanks to our amazing collaborators @KaminskiMed and @ivanorosas and their teams for the creation of this very important resource on pulmonary fibrosis. Every gene that's measured, every paper that's written, gets us one step closer to #CurePF!
2 years ago
Excited that this collaboration enables us to advance our pipeline and create new therapeutic options! #patients #collaboration #ulcerativecolitis #AI #drugdiscovery
2 years ago
Thrilled to see the results of our collaborative work with @KaminskiMed and Rosas labs out! cc @jonas_schupp, @SergioPoli and Taylor Adams
3 years ago
Congratulations to @NuMedii cofounder @atulbutte for the @aimbe award in recognition of his "outstanding contributions to creating a #precisionmedicine roadmap with #openaccess data, enabling the discovery of novel therapeutics and diagnostics"!
NuMedii photo
Atul Butte @atulbutte
Finally, I can announce what a real honor it is for me to be inducted into the American Institute for Medical and Biological Engineering @AIMBE today! #AIMBE2019

Join us on Facebook.